BioCentury
ARTICLE | Company News

Synergen Inc. sales and marketing update

November 1, 1993 8:00 AM UTC

SYGN reported a loss of $18.2 million (72 cents per share) on revenues of $4.7 million in the third quarter. vs a loss of $2.2 million (9 cents) on revenues of $16.5 million in last year's quarter ended Sept. 30. Revenue from sponsored R&D and interest income was down $13.8 million. R&D expenses were up more than $4 million to $19.4 million. ...